Succinate, an intermediate in the TCA cycle, has been highlighted for its role in TAM polarization and EMT induction in lung cancer through activation of the succinate receptor 1 (SUCNR1) and subsequent triggering of the PI3K/HIF-1α pathway. Here, SUCNR1 is linked to lung carcinoma.